Connecting and Collaborating

Connecting and Collaborating

CONNECTING AND COLLABORATING Five years of growing life sciences within London and the greater south east of England 2 CONNECTING AND COLLABORATING Introduction In 2014 the Mayor of London and south east and the UK digital health Alan Turing Institute for data the London Academic Health Science segment employs 11,000 people with science and AI. Last but not least, Centres launched MedCity with a a turnover of £1.4 billion1. Nearly we have had two Life Sciences Sector clear purpose. MedCity was to unite a quarter of Europe’s advanced Deals which are fully aligned with the elements of our life sciences sector therapy medicinal product (ATMP) the sector’s interests. to allow it to reach its full economic developers are headquartered in the potential on a world stage. UK2, and we are using licensed cell Five years on from its launch, Eliot Forster, and gene therapies to treat 100s of MedCity’s fundamental purpose to Chair MedCity At the time we knew we were at the patients in UK hospitals3. Last year enable the life sciences sector to beginning of an era of new healthcare we completed the 100,000 genomes deliver economic growth remains innovations in terms of digital health project and, in the next five years, intact. Despite political upheavals, technologies, advanced therapeutics, the government will expand it to see the sector continues to deliver and, genomics and big data. As a city, a 1 million whole genomes sequenced. through wider collaboration across region and a country, we had a world- This makes London the only city in the geographical boundaries, we can leading advantage in these fields, but world fully ready to take on the next ensure the UK life sciences sector has we had to be committed and cohesive life sciences challenges where data the leading position it deserves on a to ensure we could convert this into meets biology meets AI. global stage. a life sciences sector that would be internationally competitive and We have seen the development Together with its partners, MedCity contribute to the nation’s health. of world-leading institutes, such will continue to work to achieve as the Francis Crick Institute, the its objectives and, like the sector it Over the five years since our UK Dementia Research Institute represents, it will do so passionately, launch, MedCity has listened to the headquartered at UCL and the innovatively and effectively. sector and put in a place a wealth of impactful initiatives. Thanks to the enduring support of the London 1 BioScience and Health Funded by Technology Sector AHSCs, we have seen collaboration Statistics, Office for Life becoming more widespread and more Sciences, 2018 intuitive, and the effects of this are 2 The UK’s ATMP Landscape, BIA and visible in our region and more widely Alliance for Regenerative across the UK landscape. Medicine, 2019 In Collaboration with 3 Cell & Gene Therapy Catapult Annual Review, We have a thriving digital health 2019 community in London and the greater 3 MedCity DigitalHealth. Launch of our London is FEB FEB ‘Collaborate launched with to Innovate’ MedCity as one programme to fund MedCity is a not-for-profit organisation that of the founding life sciences SMEs delivery partners works across London and the greater south east to collaborate 2016 alongside the of England to connect the life sciences excellence with academics on London AHSNs of our academic institutes, our companies and our research healthcare system. Launched in 2014, our aim is to promote and grow life sciences investment, entrepreneurship and industry. Our report ‘Demand for APR healthcare R&D space in London’ is published By drawing on the expertise of our founders and by listening We take our first which helps form to the different voices within our ecosystem, we establish OCT delegation to the vision for several BioJapan and launch innovative developments activities and initiatives to provide deeper, more effective our report on ‘Cell across London collaboration and to raise awareness globally of the region’s and gene therapy in rich life sciences cluster. London, Oxford and Cambridge’ 2017 We are extremely grateful to our funders and supporters for the foresight and long-term commitment to this project, Our ‘London Life JUL Sciences in focus’ which has allowed MedCity to add value to the life sciences report is published We organise the ecosystem over the last five years. FEB first showcase event for NIHR Biomedical Research Centres in the region We co-host JAN the first Future of Healthcare Our ‘Neuroscience Investor Forum APR Network’ report is with the London published on research 2015 Stock Exchange on neurodegenerative disease in the region 2014 APR JUN OCT Launch of We take our first Launch of Angels MedCity delegation to in MedCity Bio International programme Convention in the US 4 CONNECTING AND COLLABORATING 2019 FEB FEB MAR APR NICE publishes Our CEO gives The British Library MedCity Our front door DEC evidence standards evidence to signs an agreement becomes an serves our 1000th framework for the House of for the creation endorsing body new client since digital healthcare Commons Science of a new R&D for life sciences our launch in 2014 technologies. and Technology hub in London’s innovator and We are on the Select Committee Knowledge Quarter start-up visas working group on balance of R&D – MedCity worked spending with partners to evolve the vision Together with NOV London Advanced Therapies we launch the Advanced Our Therapies Network (ATN) for academics, highlights 1000 £5.6M companies and clients raised investors We become 1000 new clients Three rounds of 77 companies on Angels JAN a supporter from across academia, Collaborate to Innovate in MedCity raising over of the NHS industry and the NHS - bringing together SMEs £5.6 million through the England Clinical over a third from and academics on programme1 Entrepreneur outside the UK research projects 2018 Training See page 20 Programme See page 14 See page 18 Business Minister, OCT Lord Prior, joins MedCity delegation to BioJapan Over 480 members2 in Eleven MedCity Five Future of 10,000 views3 of the Advanced Therapies delegations to Healthcare Investor the NICE evidence Network (ATN) leading international Forums co-hosted standards framework See page 19 conventions with the London Stock for digital healthcare See page 14 Exchange technologies – MedCity See page 20 leads on industry 1 As of 04/2019 engagement 2 As of 09/2019 See page 24 3 As of 09/2019 5 Our partners MedCity works in partnership with a range of Standards and Guidance organisations. We owe the success of our initiatives to 37 British Standards Institute their shared ambition and motivation in realising our goal 38 National Institute for Health and of a more connected, productive life sciences sector for Care Excellence the region and the UK. Trade bodies and Associations 39 Association of British HealthTech Industries (ABHI) 40 National Research and Innovation NHS Research and Innovation UK BioIndustry Association (BIA) 41 The Institution of Engineering and 1 National Phenome Centre 21 NHS Health Research Authority Technology 2 The Institute of Cancer Research 22 NIHR Cardiovascular MedTech 42 Association of British 3 Cell and Gene Therapy Catapult Co-operative Pharmaceutical Industry (ABPI) 23 4 Genomics England NIHR Applied Research Japan Collaboration Northwest London 5 Medicines Discovery Catapult Link-J 24 NIHR Brain Injury MedTech 6 Cardiovascular Device Hub Japanese BioIndustry Association Co-operative 7 The Francis Crick Institute 25 UCL Partners Accelerators, Incubators 8 Innovate UK 26 Imperial College Academic Health and Science Parks 9 NIHR Invention for Innovation Science Centre 43 Co-Innovate (i4i) Programme 27 King’s Health Partners 44 DigitalHealth.London Accelerator 28 NIHR Biomedical Research Centres Eastern Academic Health Science 45 MedTech SuperConnector Network (EAHSN) 10 Oxford BRC 46 NHS Innovation Accelerator 29 Imperial College Health Partners 11 Cambridge BRC 47 Oxford BioEscalator 30 Health Innovation Network 12 GOSH BRC 48 Simulation for Digital Health 31 Northern Alliance ATTC (SimDH) 13 Royal Marsden BRC 32 iMATCH ATTC 49 NHS England Clinical Entrepreneur 14 Imperial BRC 33 Midland Wales ATTC Training Programme 15 Guy’s and St Thomas’ BRC 34 NIHR London IVD Co-operative 50 Immerse UK 16 Moorfields BRC 35 NIHR Community Healthcare 51 Health Foundry 17 University College London MedTech and In Vitro Diagnostics 52 Milton Park Hospitals BRC Co-operative 53 Discovery Park Kent 18 Oxford Health BRC 36 Wessex AHSN 54 Stevenage Bioscience Catalyst 19 Maudsley BRC 20 Barts BRC 6 CONNECTING AND COLLABORATING Regional organisation 55 DigitalHealth.London 56 London & Partners 57 EDINBURGH Northern Health Science Alliance 31 (NHSA) 58 Invest Essex 59 South East Health Technologies CAMBRIDGE Alliance (SEHTA) 60 Health Innovation Research Alliance 31 Northern Ireland (HIRANI) Ipswich NEWCASTLE 61 Life Sciences Hub Wales 62 London Advanced Therapies BELFAST Milton Keynes 32 63 One Nucleus 60 49 M1 M11 Colchester LEEDS New York 57 26 New York City Economic Development Corporation MANCHESTER 5 OXFORD 32 LIVERPOOL LONDON 33 M25 M40 CAMBRIDGE 11 24 56 44 7 33 63 20 41 28 17 36 6 47 54 12 50 16 10 Reading 42 29 4 62 M4 26 OXFORD 14 46 25 39 35 18 9 52 LONDON 19 30 55 56 43 CARDIFF (see inset) 57 33 61 8 45 21 48 33 34 53 1 3 15 22 23 40 2 51 27 Canterbury 13 38 36 37 M25 M20 M3 Dover 7 Hastings Brighton Portsmouth Impact in numbers MedCity front door service Angels in MedCity (Oct 2014 to April 2019) Cumulative number 994 of new clients

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    28 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us